Appendage Management was AtriCure’s largest region in fiscal 2025, bringing in $178.13M of $437.82M (41%).
| Geography | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Appendage Management | $112.56M | $134.48M | $151.59M | $178.13M | ||||||||||
| Open Ablation | $86.12M | $105.29M | $123.65M | $143.85M | ||||||||||
| Open-Heart Ablation | — | — | — | — | ||||||||||
| Open-Heart | — | — | — | — | ||||||||||
| Pain Management | $39.97M | $49.20M | $61.84M | $81.92M | ||||||||||
| Ablation & Appendage Management | — | — | — | — | ||||||||||
| Minimally Invasive Ablation | $38.55M | $44.58M | $45.74M | $31.48M | ||||||||||
| Minimally Invasive | — | — | — | — | ||||||||||
| Total Ablation | — | — | — | — | ||||||||||
| Atriclip Devices | — | — | — | — | ||||||||||
| Atriclip | — | — | — | — | ||||||||||
| Valve Tools | — | — | — | — | ||||||||||
| Shipping & Handling | $1.50M | $1.86M | $2.42M | $2.45M | ||||||||||
| Total | $278.70M | $335.40M | $385.24M | $437.82M |
AtriCure brought in $437.82M from its five regions in fiscal 2025, the year ended December 31, 2025. That was up 13.7% from $385.24M in fiscal 2024. Appendage Management was the largest at $178.13M (40.7%), ahead of Open Ablation at $143.85M (32.9%) and Pain Management at $81.92M (18.7%). The other two regions brought in $33.93M combined.
Compared with fiscal 2024, Pain Management grew fastest, up 32.5% to $81.92M, while Minimally Invasive Ablation fell the most, down 31.2% to $31.48M. From fiscal 2022 to 2025, combined revenue from these regions grew from $278.70M to $437.82M, a compound annual growth rate of 16.2%. Appendage Management's share held steady at about 40.7%.
United States was AtriCure’s largest region in fiscal 2025, bringing in $178.13M of $314.95M (57%).
| Geography | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $86.12M | $105.29M | $151.59M | $178.13M | ||||||||||||
| Total International | $79.99M | $65.70M | $82.49M | $99.16M | ||||||||||||
| International | — | — | — | — | ||||||||||||
| Open-Heart | — | — | — | — | ||||||||||||
| Openheart | — | — | — | — | ||||||||||||
| Asia-Pacific | $20.73M | $24.53M | $27.38M | $30.72M | ||||||||||||
| Europe | $30.43M | $38.47M | $49.87M | — | ||||||||||||
| Minimally Invasive | — | — | — | — | ||||||||||||
| Segment Geographical Groups Of Countries Group One | — | — | — | — | ||||||||||||
| Asia | — | — | — | — | ||||||||||||
| Atriclip | — | — | — | — | ||||||||||||
| Articlip | — | — | — | — | ||||||||||||
| Other International | $2.02M | $2.71M | $5.24M | $6.94M | ||||||||||||
| Total | $219.28M | $236.69M | $316.57M | $314.95M |
AtriCure brought in $314.95M from its four regions in fiscal 2025, the year ended December 31, 2025. That is less than the $437.82M it reports by geography, so these regions do not cover all of its revenue. United States was the largest at $178.13M (56.6%), ahead of Total International at $99.16M (31.5%) and Asia-Pacific at $30.72M (9.8%). The remaining region, Other International, brought in $6.94M.
Compared with fiscal 2024, Other International grew fastest, up 32.5% to $6.94M. Every region above 2% of revenue grew. Some of that change comes from AtriCure regrouping its regions.
AtriCure stopped reporting Europe as a separate region after fiscal 2024, when it brought in $49.87M.
Domestic was AtriCure’s largest region in fiscal 2011, bringing in $29.20M of $40.41M (72%).
| Geography | FY 2011 |
|---|---|
| Domestic | $29.20M |
| International | $11.21M |
| Total | $40.41M |
AtriCure brought in $40.41M from its two regions in fiscal 2011, the year ended December 31, 2011. Domestic was the largest at $29.20M (72.3%), ahead of International at $11.21M (27.7%).
AtriCure (ATRC) reports its revenue by geography. In fiscal 2025, Appendage Management was its largest region, bringing in $178.13M (40.7% of the total), followed by Open Ablation at $143.85M (32.9%).
Appendage Management was AtriCure's largest region in fiscal 2025, bringing in $178.13M, or 40.7% of the $437.82M total across its five regions.
Among AtriCure's regions that make up at least 2% of revenue, Pain Management grew fastest in fiscal 2025, up 32.5% from $61.84M to $81.92M.
Every figure comes from AtriCure's annual financial filings, as reported. Each line keeps the name AtriCure gives it, and years follow its fiscal calendar.
AtriCure's revenue by geography goes back to fiscal 2012, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.